Global Smoking Cessation Drugs Market Professional Survey Report 2019
Smoking cessation (also known as quitting smoking or simply quitting) is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive. Nicotine withdrawal makes the process of quitting often very prolonged and difficult.
Americas accounted for almost 42% of the market share and is expected to grow at a CAGR of around 13% during the forecast period. The decline in smoker’s population due to rising health consciousness and the increased preference for the use of e-cigarettes and nicotine replacement therapy products are the primary drivers for the market growth in this region.
The global Smoking Cessation Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Smoking Cessation Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Smoking Cessation Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Smoking Cessation Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Smoking Cessation Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy's Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
NRTs Products
Nicotine-Free Products
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Americas accounted for almost 42% of the market share and is expected to grow at a CAGR of around 13% during the forecast period. The decline in smoker’s population due to rising health consciousness and the increased preference for the use of e-cigarettes and nicotine replacement therapy products are the primary drivers for the market growth in this region.
The global Smoking Cessation Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Smoking Cessation Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Smoking Cessation Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Smoking Cessation Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Smoking Cessation Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy's Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
NRTs Products
Nicotine-Free Products
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
